BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17325908)

  • 1. Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.
    Shinohara A; Asai T; Izutsu K; Ota Y; Takeuchi K; Hangaishi A; Kanda Y; Chiba S; Motokura T; Kurokawa M
    Leuk Lymphoma; 2007 Feb; 48(2):418-20. PubMed ID: 17325908
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphoma.
    Park S; Noguera ME; Brière J; Feuillard J; Cayuela JM; Sigaux F; Brice P
    Hematol J; 2002; 3(6):317-20. PubMed ID: 12522456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Heath JA; Broxson EH; Dole MG; Filippa DA; George D; Lyden D; Dunkel IJ
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia.
    Matsue K; Itoh M; Tsukuda K; Kokubo T; Hirose Y
    Int J Hematol; 1998 Apr; 67(3):319-29. PubMed ID: 9650454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
    Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
    Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
    [No Abstract]   [Full Text] [Related]  

  • 7. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
    Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
    Smeltzer JP; Viswanatha DS; Habermann TM; Patnaik MM
    Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
    Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
    Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
    Yamagata M; Murohisa T; Tsuchida K; Okamoto Y; Tsunoda S; Nakamura M; Kusano K; Majima Y; Kuniyoshi T; Iijima M; Sugaya H; Hiraishi H
    Leuk Lymphoma; 2007 Feb; 48(2):431-3. PubMed ID: 17325912
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab for bone lymphoma.
    Savage DG; Staron R
    Ann Intern Med; 2001 Jun; 134(12):1156-7. PubMed ID: 11412072
    [No Abstract]   [Full Text] [Related]  

  • 12. Intra-vascular large B-cell lymphoma revealed by a nephrotic syndrome: a one year remission induced by a high frequency CHOP and rituximab.
    Girard T; Nochy D; Montravers F; Der Sahakian G; Fior R; Galanaud P; Boué F
    Leuk Lymphoma; 2004 Aug; 45(8):1703-5. PubMed ID: 15370230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus, B cells, T cells, and a lymphoproliferative disorder.
    Ott G; Ott MM; Müller-Hermelink HK
    Lancet; 1994 Apr; 343(8902):922. PubMed ID: 7908386
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab for early-stage diffuse large-B-cell lymphoma.
    Friedberg JW
    Lancet Oncol; 2006 May; 7(5):357-9. PubMed ID: 16648037
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma.
    Micallef IN; Kirk A; Norton A; Foran JM; Rohatiner AZ; Lister TA
    Blood; 1999 Apr; 93(7):2427-8. PubMed ID: 10215354
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab for BCL-2-positive cancers.
    Boughton B
    Lancet Oncol; 2003 Feb; 4(2):69. PubMed ID: 12573343
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma.
    Imamura T; Yoshihara T; Morimoto A; Ishida H; Sugimoto T; Imashuku S
    Pediatr Hematol Oncol; 2006; 23(1):19-24. PubMed ID: 16326408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in the treatment of EBV-positive low grade B-cell lymphoma.
    Diamantopoulos PT; Polonyfi K; Sofotasiou M; Papadopoulou V; Kalala F; Iliakis T; Zervakis K; Tsilimidos G; Kouzis P; Kyrtsonis MC; Vassilakopoulos T; Angelopoulou M; Siakantaris M; Vayopoulos G; Kollia P; Pangalis G; Viniou NA
    Anticancer Res; 2013 Dec; 33(12):5693-8. PubMed ID: 24324119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral T-cell lymphoma complicated by a proliferation of large B cells.
    Higgins JP; van de Rijn M; Jones CD; Zehnder JL; Warnke RA
    Am J Clin Pathol; 2000 Aug; 114(2):236-47. PubMed ID: 10941339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.